Reactive oxygen signaling molecule inducible regulation of CRISPR-Cas9 gene editing

被引:0
|
作者
Zhao, Jizhong [1 ]
Hu, Hongmei [1 ]
Zhou, Hongling [1 ]
Zhang, Jingwen [1 ]
Wang, Li [2 ]
Wang, Rui [1 ,3 ]
机构
[1] Huazhong Univ Sci & Technol, Sch Pharm, Tongji Med Coll, Hubei Key Lab Nat Med Chem & Resource Evaluat, Wuhan 430030, Peoples R China
[2] Huazhong Univ Sci & Technol, Wuhan Hosp 1, Wuhan 430022, Peoples R China
[3] Shenzhen Huazhong Univ, Sci & Technol Res Inst, Shenzhen 518057, Guangdong, Peoples R China
关键词
Cas9; Regulation; Boronated; gRNA; ROS; SYSTEM;
D O I
10.1007/s10565-022-09723-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We report development of a controllable gene editing tool that boronated gRNA, simply generated in situ, could regulate binding of gRNA molecules with either Cas9 endonuclease or target genes, thus serving as a modulator that can control CRISPR-Cas9 gene editing. Subsequent treatment with H2O2 facilitates the restoration of gene editing ability of the boronated gRNA to the level of using untreated gRNA. This is one of the few cases using small molecule to regulate CRISPR-Cas9 gene editing, which is a complement to the light approach, displaying great application potential.
引用
收藏
页码:2421 / 2429
页数:9
相关论文
共 50 条
  • [1] Reactive oxygen signaling molecule inducible regulation of CRISPR-Cas9 gene editing
    Jizhong Zhao
    Hongmei Hu
    Hongling Zhou
    Jingwen Zhang
    Li Wang
    Rui Wang
    Cell Biology and Toxicology, 2023, 39 (5) : 2421 - 2429
  • [2] Inducible in vivo genome editing with CRISPR-Cas9
    Dow, Lukas E.
    Fisher, Jonathan
    O'Rourke, Kevin P.
    Muley, Ashlesha
    Kastenhuber, Edward R.
    Livshits, Geulah
    Tschaharganeh, Darjus F.
    Socci, Nicholas D.
    Lowe, Scott W.
    NATURE BIOTECHNOLOGY, 2015, 33 (04) : 390 - U98
  • [3] Inducible in vivo genome editing with CRISPR-Cas9
    Lukas E Dow
    Jonathan Fisher
    Kevin P O'Rourke
    Ashlesha Muley
    Edward R Kastenhuber
    Geulah Livshits
    Darjus F Tschaharganeh
    Nicholas D Socci
    Scott W Lowe
    Nature Biotechnology, 2015, 33 : 390 - 394
  • [4] Controlling CRISPR-Cas9 Gene Editing
    Dowdy, Steven F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (03): : 289 - 290
  • [5] Introduction to CRISPR-Cas9 Gene Editing
    Mason, J. M.
    BIRTH DEFECTS RESEARCH, 2020, 112 (11): : 809 - 809
  • [6] Gene Editing of Human Hepatocytes by CRISPR-Cas9
    Zhang, Qingshuo
    Tiyaboonchai, Amita
    Balaji, Niveditha
    Naugler, Willscott
    Grompe, Markus
    MOLECULAR THERAPY, 2018, 26 (05) : 367 - 367
  • [7] CRISPR-cas9 Gene Editing for Cystic Fibrosis
    Xia, Emily
    MOLECULAR THERAPY, 2019, 27 (04) : 196 - 196
  • [8] CRISPR-Cas9 gene editing and human diseases
    Jinka, Chaitra
    Sainath, Chithirala
    Babu, Shyamaladevi
    Chakravarthi, Chennupati Ashok
    Prasanna, Muppidi Lakshmi
    Krishnan, Madhan
    Sekar, Gayathri
    Chinnaiyan, Mayilvanan
    Kumari, Andugula Swapna
    BIOINFORMATION, 2022, 18 (11) : 1081 - 1086
  • [9] CRISPR-Cas9 gene editing for patients with haemoglobinopathies
    不详
    LANCET HAEMATOLOGY, 2019, 6 (09): : E438 - E438
  • [10] Application of CRISPR-Cas9 gene editing to treat HBV
    Yan, Kun
    Feng, Jiangpeng
    Xiong, Yong
    Chen, Yu
    CHINESE SCIENCE BULLETIN-CHINESE, 2019, 64 (30): : 3142 - 3150